The industry analysis specialist, has released a new report on the Pharmaceutical and Healthcare industry, “Angina Pectoris – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global angina pectoris market. The report identifies the key trends shaping and driving the global angina pectoris market, a key segment within the pharma industry. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global angina pectoris sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Scope
The scope of the report includes:
- Annualized global angina pectoris market revenue data from 2001 to 2009, forecast forward 7 years to 2016.
- Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action includes gene therapy, combinational therapies, nitric oxide targettors, beta-1 adrenergic receptor antagonists, stem cell therapy, enzyme inhibitors, immunologic drugs, coagulation factor Xa inhibitors, adenosine A1 agonists, anticoagulants and calcium/potassium and sodium channel blockers.
- Analysis of the current and future market competition in the global angina pectoris market. The key market players covered are Solvay Pharmaceuticals, Cardium Therapeutics, Inc., Bayer Healthcare AG., Atherogenics, Inc., Cytokinetics, Inc, Arca Biopharma, Inc., Anthera Pharmaceuticals, Inc, Lacer S.A and Circ Pharma.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with angina pectoris
For More Information Please Click :
http://www.aarkstore.com/reports/Angina-Pectoris-Drug-Pipeline-Analysis-and-Mark Or Call Us: 919272852585
Visit Our Blog: http://blogs.aarkstore.com
Keywords: Market forecast, revenues, unmet need, drivers, barriers, pharma, clinical trials, marketed products, pipeline, promising drugs, future players, key companies, strategic competitor assessment, market characterization, implications for future market, mechanism of action
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Scope
The scope of the report includes:
- Annualized global angina pectoris market revenue data from 2001 to 2009, forecast forward 7 years to 2016.
- Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action includes gene therapy, combinational therapies, nitric oxide targettors, beta-1 adrenergic receptor antagonists, stem cell therapy, enzyme inhibitors, immunologic drugs, coagulation factor Xa inhibitors, adenosine A1 agonists, anticoagulants and calcium/potassium and sodium channel blockers.
- Analysis of the current and future market competition in the global angina pectoris market. The key market players covered are Solvay Pharmaceuticals, Cardium Therapeutics, Inc., Bayer Healthcare AG., Atherogenics, Inc., Cytokinetics, Inc, Arca Biopharma, Inc., Anthera Pharmaceuticals, Inc, Lacer S.A and Circ Pharma.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with angina pectoris
For More Information Please Click :
http://www.aarkstore.com/reports/Angina-Pectoris-Drug-Pipeline-Analysis-and-Mark
Or Call Us: 919272852585
Visit Our Blog: http://blogs.aarkstore.com
Keywords: Market forecast, revenues, unmet need, drivers, barriers, pharma, clinical trials, marketed products, pipeline, promising drugs, future players, key companies, strategic competitor assessment, market characterization, implications for future market, mechanism of action